NEWBURYPORT, MA — (Marketwire) — 05/30/12 — PCI Synthesis, Inc. (), a 12-year-old custom chemical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and other specialty chemical products, today announced that industry veteran Alexander Tretyakov has joined the company as Vice President of Research and Development.In this role, Tretyakov will provide technical leadership across the company, specifically in creating de novo synthetic schemes and ap
As always kg-pharma exhibits this year during TechnoPharm (27-29/04) in Nuremberg and again we will present you a number of new developments:
